Parkinson’s Disease and Movement Disorders

Abstract

Biochemical and functional organization of the basal ganglia dopamine systems in the mammalian brain brain dopamine receptors - characterization, distribution and alteration in disease MPTP-induced Parkinsonism - a model of Parkinson's disease and its relevance to the disease process pathophysiology of Parkinson's signs the etiology of Parkinson's disease - new directions for research L-Dopa in Parkinson's disease - mechanisms of action and pathophysiology of late failure therapeutic strategies in Parkinson's disease progressive supranuclear palsy olivopontocerebellar atrophy shy-drager syndrome Huntington's disease early onset of Parkinsonism the neuropathology of Parkinsonian disorders clinical rating scale for tremor rating scales in Parkinson's disease tremors - differential diagnosis and pharmacology different clinical presentations of myoclonous tics dystomic syndromes the pathophysiology of drug-induced movement disorders drug-induced dyskinesias akathisia and the restless legs syndrome ataxia and other cerebellar syndromes gait disorders spasticity and rigidity muscle cramps, stiffness and myalgia cognitive impairments associated with Parkinson's disease and other movement disorders magnetic resonance of movement disorder surgery for movement disorders neural transplantation mitochondrial disease and movement disorders PET studies of Parkinsonian subjects - human and animal experiments.